Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in India
Venus , Remedies , Metx , Critical , Antibiotic , Development , Will , Therapeutics , Resistance , …
Venus , Remedies , Metx , Critical , Antibiotic , Development , Will , Therapeutics , Resistance , …
“Only 9% students show high readiness in essential skills ” says Primus Partners report : ‘Shapi…
The Central Teacher Eligibility Test (CTET) is scheduled to take place on September 21, 2014. The…
Ransomware,Threats,Malware,India,Cybersecurity,Email,Security,Trend,Asia,Report,Ranks,Globally,Crit…
HIGHLIGHTS OF THE UNION BUDGET 2024-25 Posted On: 23 JUL 2024 1:17PM by PIB Delhi The Union…
Business , International , Global , Bimtech , Students , Trade , Management , Platform , Discussion…
Mankind Pharma Completes Landmark Acquisition of BSV Expands high entry barrier portfolio; Leader…
Bihar Hosts Fifth State-Level Consultation on Glaucoma Prevention Patna, 10th March 2025 – Under…